Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study
1 AARA Research Center, 10100 N. Central Expressway, Suite 100, Dallas, TX, 75231, USA. Lumrymd@AARAResearch.com.
2 Department of Medicine, UC San Diego, La Jolla, CA, USA.
3 University of Milan, Milan, Italy.
4 Penn State University College of Medicine, Hershey, PA, USA.
5 Clinical Research Center of Alabama, Birmingham, AL, USA.
6 Massachusetts General Hospital, Boston, MA, USA.
7 University of Cincinnati College of Medicine and Bernstein Clinical Research Center, LLC, Cincinnati, OH, USA.
8 Allergy Department, Hospital La Paz Institute for Health Research (IdiPaz), Biomedical Research Network On Rare Diseases (CIBERER U754), Madrid, Spain.
9 Hungarian Angioedema Reference Center, 3Rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
10 Maryclif Clinical Research, Spokane, WA, USA.
11 McMaster University, Hamilton, ON, USA.
12 UC Irvine, Orange, CA, USA.
13 Institute for Asthma and Allergy, Chevy Chase, MD, USA.
14 Department of Dermatology and Allergy, Charité, Universitätsmedizin Berlin, Berlin, Germany.
15 Medical Research of Arizona, Scottsdale, AZ, USA.
16 Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, USA.